Blood Group Test Cards Market Report – Research, Industry Analysis Reports and Market Demands

Global Blood Group Test Cards Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Blood Group Test Cards Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Universal Blood Type Test Card
- 1.3.3 Special Blood Type Test Card
1.4 Market Analysis by Detection Principle
- 1.4.1 Overview: Global Blood Group Test Cards Consumption Value by Detection Principle: 2021 Versus 2025 Versus 2032
- 1.4.2 Gel / Column Agglutination Cards
- 1.4.3 Glass-Bead & Micro-Bead Cards
- 1.4.4 Dry Reagent Agglutination Cards
- 1.4.5 Others
1.5 Market Analysis by Automation
- 1.5.1 Overview: Global Blood Group Test Cards Consumption Value by Automation: 2021 Versus 2025 Versus 2032
- 1.5.2 Manual POCT Cards
- 1.5.3 Bench-Top Incubator + Centrifuge
- 1.5.4 Fully Automated Analyzer Cards
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Blood Group Test Cards Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Household
- 1.6.3 Hospital
- 1.6.4 Clinic
- 1.6.5 Others
1.7 Global Blood Group Test Cards Market Size & Forecast
- 1.7.1 Global Blood Group Test Cards Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Blood Group Test Cards Sales Quantity (2021-2032)
- 1.7.3 Global Blood Group Test Cards Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Blood Group Test Cards by Manufacturer

3.1 Global Blood Group Test Cards Sales Quantity by Manufacturer (2021-2026)
3.2 Global Blood Group Test Cards Revenue by Manufacturer (2021-2026)
3.3 Global Blood Group Test Cards Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Blood Group Test Cards by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Blood Group Test Cards Manufacturer Market Share in 2025
- 3.4.3 Top 6 Blood Group Test Cards Manufacturer Market Share in 2025
3.5 Blood Group Test Cards Market: Overall Company Footprint Analysis
- 3.5.1 Blood Group Test Cards Market: Region Footprint
- 3.5.2 Blood Group Test Cards Market: Company Product Type Footprint
- 3.5.3 Blood Group Test Cards Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Blood Group Test Cards Market Size by Region
- 4.1.1 Global Blood Group Test Cards Sales Quantity by Region (2021-2032)
- 4.1.2 Global Blood Group Test Cards Consumption Value by Region (2021-2032)
- 4.1.3 Global Blood Group Test Cards Average Price by Region (2021-2032)
4.2 North America Blood Group Test Cards Consumption Value (2021-2032)
4.3 Europe Blood Group Test Cards Consumption Value (2021-2032)
4.4 Asia-Pacific Blood Group Test Cards Consumption Value (2021-2032)
4.5 South America Blood Group Test Cards Consumption Value (2021-2032)
4.6 Middle East & Africa Blood Group Test Cards Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Blood Group Test Cards Sales Quantity by Type (2021-2032)
5.2 Global Blood Group Test Cards Consumption Value by Type (2021-2032)
5.3 Global Blood Group Test Cards Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Blood Group Test Cards Sales Quantity by Application (2021-2032)
6.2 Global Blood Group Test Cards Consumption Value by Application (2021-2032)
6.3 Global Blood Group Test Cards Average Price by Application (2021-2032)

7 North America

7.1 North America Blood Group Test Cards Sales Quantity by Type (2021-2032)
7.2 North America Blood Group Test Cards Sales Quantity by Application (2021-2032)
7.3 North America Blood Group Test Cards Market Size by Country
- 7.3.1 North America Blood Group Test Cards Sales Quantity by Country (2021-2032)
- 7.3.2 North America Blood Group Test Cards Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Blood Group Test Cards Sales Quantity by Type (2021-2032)
8.2 Europe Blood Group Test Cards Sales Quantity by Application (2021-2032)
8.3 Europe Blood Group Test Cards Market Size by Country
- 8.3.1 Europe Blood Group Test Cards Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Blood Group Test Cards Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Blood Group Test Cards Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Blood Group Test Cards Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Blood Group Test Cards Market Size by Region
- 9.3.1 Asia-Pacific Blood Group Test Cards Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Blood Group Test Cards Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Blood Group Test Cards Sales Quantity by Type (2021-2032)
10.2 South America Blood Group Test Cards Sales Quantity by Application (2021-2032)
10.3 South America Blood Group Test Cards Market Size by Country
- 10.3.1 South America Blood Group Test Cards Sales Quantity by Country (2021-2032)
- 10.3.2 South America Blood Group Test Cards Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Blood Group Test Cards Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Blood Group Test Cards Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Blood Group Test Cards Market Size by Country
- 11.3.1 Middle East & Africa Blood Group Test Cards Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Blood Group Test Cards Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Blood Group Test Cards Market Drivers
12.2 Blood Group Test Cards Market Restraints
12.3 Blood Group Test Cards Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Blood Group Test Cards and Key Manufacturers
13.2 Manufacturing Costs Percentage of Blood Group Test Cards
13.3 Blood Group Test Cards Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Blood Group Test Cards Typical Distributors
14.3 Blood Group Test Cards Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Blood Group Test Cards market size was valued at US$ 897 million in 2025 and is forecast to a readjusted size of US$ 1240 million by 2032 with a CAGR of 4.8% during review period.
Blood Group Test Cards are IVD consumables that integrate ABO/Rh and related blood-group reagents into plastic cards using gel/column agglutination, glass-bead, or dry agglutination, serving pre-transfusion testing, donor screening, neonatal testing and POC / self-testing.
Supply chain – monoclonal antibodies & AHG, gel / bead matrix and plastic cards upstream; card filling and automation mid-stream; hospitals, blood banks, labs, emergency services and home users downstream.
Ex-factory prices range from US$0.1 per blank card to US$1–6 per professional test and US$15–25 per consumer kit, with typical gross margins around 45–60% in line with high-value IVD reagents.
As a fundamental tool in the blood safety assurance system, blood group test cards derive their development momentum from the efficiency demands of emergency medical scenarios, breakthroughs in technological innovation, and the continuous growth of global blood demand. In emergency medical fields, traditional blood group testing methods rely on laboratory equipment and are cumbersome to operate. In contrast, blood group test cards, with the advantage of delivering results in as little as 30 seconds, have become core equipment in resource-scarce scenarios such as field rescue, battlefield medical treatment, and disaster area healthcare. They save critical time for transfusion decisions and effectively reduce the risk of transfusion adverse reactions such as hemolysis. The upgrading of clinical medical needs has further promoted the expansion of their functions, ranging from basic ABO blood group preliminary screening to synchronous detection of ABO forward and reverse typing, Rh typing, and even rare blood group systems such as P and KELL, adapting to the precise needs of complex medical scenarios such as surgical preparation and organ transplantation. Technological innovation is one of the core driving forces. The specific combination technology of dye reagents and antigen-antibody reactions allows test results to be presented through intuitive color changes between blue-green and reddish-brown, which not only simplifies the operation process but also reduces reliance on professional operators. The integration of microfluidic technology has further improved the stability and anti-interference ability of detection. The increasing emphasis on blood safety in the global medical system, the strict regulatory requirements for blood donation and transfusion links, and the policy support from various countries for improving the diagnostic capabilities of primary medical care have collectively opened up a broad market space for blood group test cards. Their advantages in convenience and economy are particularly prominent in areas with relatively weak medical resources. However, the development of blood group test cards still faces multiple challenges. There are specific difficulties in controlling detection accuracy. Although the accuracy rate for common blood groups has reached a high level, the risk of errors caused by rare blood groups has not been completely eliminated, and there is an urgent need for large-sample verification and technical optimization. Product hierarchy differentiation brings market adaptation issues. High-end automated test cards can realize multi-system synchronous detection, but their high cost makes them difficult to popularize in primary medical institutions with limited resources; while low-end products may affect the reliability of test results due to insufficient material or reagent stability. The competitive pressure from alternative technologies is also obvious. Fully automated blood group analyzers, with their highly integrated detection capabilities, are increasingly used in large hospitals and diagnostic laboratories, and their advantages in standardized operation and batch processing have squeezed the market share of traditional manual test cards. In addition, regional differences in industry regulatory standards increase the difficulty of product internationalization. Different regions have different requirements for the sensitivity, shelf life, and clinical verification of test cards, and enterprises need to invest additional resources to make compliance adjustments. The stability of raw material supply cannot be ignored either. Quality fluctuations in core raw materials such as specific antigens and dye reagents may directly affect product performance, while supply chain fluctuations may lead to risks in production continuity. In the future, with further technological maturity, blood group test cards that combine rapid detection, multi-system adaptation, and cost advantages will become the market mainstream, playing a more critical role in improving the global blood safety system.
This report is a detailed and comprehensive analysis for global Blood Group Test Cards market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Group Test Cards market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Blood Group Test Cards market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Blood Group Test Cards market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Blood Group Test Cards market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Group Test Cards
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Group Test Cards market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, Bio-Rad Laboratories, QuidelOrtho, InTec, Tulip Diagnostics, Fortress Diagnostics, Biorex Diagnostics, ELDON BIOLOGICALS A/S, JAL Innovation, Aikang Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Blood Group Test Cards market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Universal Blood Type Test Card
Special Blood Type Test Card
Market segment by Detection Principle
Gel / Column Agglutination Cards
Glass-Bead & Micro-Bead Cards
Dry Reagent Agglutination Cards
Others
Market segment by Automation
Manual POCT Cards
Bench-Top Incubator + Centrifuge
Fully Automated Analyzer Cards
Market segment by Application
Household
Hospital
Clinic
Others
Major players covered
Grifols
Bio-Rad Laboratories
QuidelOrtho
InTec
Tulip Diagnostics
Fortress Diagnostics
Biorex Diagnostics
ELDON BIOLOGICALS A/S
JAL Innovation
Aikang Diagnostics
Beijing Strong Biotechnologies
KangJia
Aikang MedTech
Zhuhai Ideal Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Group Test Cards product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Group Test Cards, with price, sales quantity, revenue, and global market share of Blood Group Test Cards from 2021 to 2026.
Chapter 3, the Blood Group Test Cards competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Group Test Cards breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Blood Group Test Cards market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Group Test Cards.
Chapter 14 and 15, to describe Blood Group Test Cards sales channel, distributors, customers, research findings and conclusion.

Buy now